Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Oncotargets and Therapy|November 15, 2018
Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case reportWan He, Xiangmei Zhang, Wenwen Li, et al.
Emerging Microbes & Infections|March 25, 2025
Differential replication, pathology, and immune response of clade IIb mpox virus in C57BL/6 and BALB/c miceMeimei Duan, Xiangmei Zhang, Xian Tang, et al.
Medicine|October 12, 2022
Real-world study of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant treatment for patients with HER2-positive breast cancerXiangmin Ma, Xiangmei Zhang, Xinping Zhou, et al.
Veterinary Research|August 19, 2022
A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challengeRui Chen, Bing Liu, Xiangmei Zhang, et al.
Clinical Breast Cancer|June 3, 2020
A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast CancerXiangmei Zhang, Zhenzhen Zhang, Miao Cao, et al.
Cancer Biology & Therapy|December 20, 2024
Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosisShang Wu, Xindi Ma, Xiangmei Zhang, et al.
Biochemical and Biophysical Research Communications|May 15, 2012
A422T mutation in HERG potassium channel retained in ER is rescurable by pharmacologic or molecular chaperonesJia Guo, XiangMei Zhang, ZhenSheng Hu, et al.
Annals of Translational Medicine|April 18, 2022
Blocking the Notch signal transduction pathway promotes tumor growth in breast cancer by promoting the expression of suppressible inflammatory factorsShuguang Ren, Yueyang Hu, Yingchao Ju, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 15, 2021
Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaJidong Zhao, Ming He, Jie Li, et al.
Oncology Research|July 4, 2025
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancerCheng Cheng, Chao Shi, Shang Wu, et al.
Pageof 9